These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 25973691)
1. The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics. Alahgholi-Hajibehzad M; Kasapoglu P; Jafari R; Rezaei N Expert Rev Clin Immunol; 2015; 11(7):859-70. PubMed ID: 25973691 [TBL] [Abstract][Full Text] [Related]
3. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis. Zhang Y; Wang HB; Chi LJ; Wang WZ Immunol Lett; 2009 Jan; 122(1):52-7. PubMed ID: 19111574 [TBL] [Abstract][Full Text] [Related]
4. CD4 Kohler S; Keil TOP; Hoffmann S; Swierzy M; Ismail M; Rückert JC; Alexander T; Meisel A Clin Immunol; 2017 Jun; 179():40-46. PubMed ID: 28286113 [TBL] [Abstract][Full Text] [Related]
5. Changes of Treg-associated molecules on CD4+CD25 +Treg cells in myasthenia gravis and effects of immunosuppressants. Xu WH; Zhang AM; Ren MS; Zhang XD; Wang F; Xu XC; Li Q; Wang J; Din BS; Wu YB; Chen GH J Clin Immunol; 2012 Oct; 32(5):975-83. PubMed ID: 22467037 [TBL] [Abstract][Full Text] [Related]
6. Undiminished regulatory T cells in the thymus of patients with myasthenia gravis. Matsui N; Nakane S; Saito F; Ohigashi I; Nakagawa Y; Kurobe H; Takizawa H; Mitsui T; Kondo K; Kitagawa T; Takahama Y; Kaji R Neurology; 2010 Mar; 74(10):816-20. PubMed ID: 20211905 [TBL] [Abstract][Full Text] [Related]
8. Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model. Gertel-Lapter S; Mizrachi K; Berrih-Aknin S; Fuchs S; Souroujon MC Autoimmun Rev; 2013 Jul; 12(9):894-903. PubMed ID: 23535156 [TBL] [Abstract][Full Text] [Related]
9. Comparative Analysis of Thymic and Blood Treg in Myasthenia Gravis: Thymic Epithelial Cells Contribute to Thymic Immunoregulatory Defects. Truffault F; Nazzal D; Verdier J; Gradolatto A; Fadel E; Roussin R; Eymard B; Le Panse R; Berrih-Aknin S Front Immunol; 2020; 11():782. PubMed ID: 32435245 [TBL] [Abstract][Full Text] [Related]
10. Reduction in peripheral regulatory T cell population in childhood ocular type myasthenia gravis. Nishimura T; Inaba Y; Nakazawa Y; Omata T; Akasaka M; Shirai I; Ichikawa M Brain Dev; 2015 Sep; 37(8):808-16. PubMed ID: 25563663 [TBL] [Abstract][Full Text] [Related]
11. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Balandina A; Lécart S; Dartevelle P; Saoudi A; Berrih-Aknin S Blood; 2005 Jan; 105(2):735-41. PubMed ID: 15454488 [TBL] [Abstract][Full Text] [Related]
12. Modeling the intrathymic pathogenesis of myasthenia gravis. Levinson AI J Neurol Sci; 2013 Oct; 333(1-2):60-7. PubMed ID: 23332143 [TBL] [Abstract][Full Text] [Related]
13. Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-α. Gradolatto A; Nazzal D; Truffault F; Bismuth J; Fadel E; Foti M; Berrih-Aknin S J Autoimmun; 2014 Aug; 52():53-63. PubMed ID: 24405842 [TBL] [Abstract][Full Text] [Related]
14. The susceptibility of Aire(-/-) mice to experimental myasthenia gravis involves alterations in regulatory T cells. Aricha R; Feferman T; Scott HS; Souroujon MC; Berrih-Aknin S; Fuchs S J Autoimmun; 2011 Feb; 36(1):16-24. PubMed ID: 21035305 [TBL] [Abstract][Full Text] [Related]
15. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Fattorossi A; Battaglia A; Buzzonetti A; Ciaraffa F; Scambia G; Evoli A Immunology; 2005 Sep; 116(1):134-41. PubMed ID: 16108825 [TBL] [Abstract][Full Text] [Related]
16. Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients. Luther C; Adamopoulou E; Stoeckle C; Brucklacher-Waldert V; Rosenkranz D; Stoltze L; Lauer S; Poeschel S; Melms A; Tolosa E J Immunol; 2009 Jul; 183(2):841-8. PubMed ID: 19542375 [TBL] [Abstract][Full Text] [Related]
17. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat. Meinl E; Klinkert WE; Wekerle H Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638 [TBL] [Abstract][Full Text] [Related]
18. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review. Huang GZ; Lo YL J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018 [TBL] [Abstract][Full Text] [Related]
19. Defects of immunoregulatory mechanisms in myasthenia gravis: role of IL-17. Gradolatto A; Nazzal D; Foti M; Bismuth J; Truffault F; Le Panse R; Berrih-Aknin S Ann N Y Acad Sci; 2012 Dec; 1274():40-7. PubMed ID: 23252896 [TBL] [Abstract][Full Text] [Related]
20. Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients. Masuda M; Matsumoto M; Tanaka S; Nakajima K; Yamada N; Ido N; Ohtsuka T; Nishida M; Hirano T; Utsumi H J Neuroimmunol; 2010 Aug; 225(1-2):123-31. PubMed ID: 20472307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]